Skip to content

Treatment of Primary Menstrual Pain With Kanion Capsule

Treatment of Primary Dysmenorrhea With Kanion Capsule (GF) A Randomized, Double-blind, Placebo-controlled, Repeated-Dose and Multi-Center Clinical Phase II Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00523146
Enrollment
Unknown
Registered
2007-08-31
Start date
2007-04-30
Completion date
2009-02-28
Last updated
2010-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea

Keywords

primary dysmenorrhea, Herbal remedy

Brief summary

The objectives of this clinical trial are: * To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects; * To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.

Interventions

DRUGKanion Capsule

Sponsors

Lianyungang Kanion Group, Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* primary dysmenorrhea

Exclusion criteria

* secondary dysmenorrhea

Design outcomes

Primary

MeasureTime frame
pain reduction6 months

Secondary

MeasureTime frame
accompanying symptoms improvement6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026